Recall | Medicines | 13/11/2018

The marketing authorization holder has informed its supplied customers by letter dated Nov. 12, 2018, that due to a slightly increased exceedance of the specification for known impurities, the above batch is being recalled.

Name of the medicinal product Rapibloc 20 mg/2 ml Konzentrat zur Herstellung einer Injektionslösung
Marketing authorisation number(s) 137586
Marketing authorisation holder Amomed Pharma GmbH
Batch number(s) 8B631A
Classification of the recall2
BASG reference number INS-640.001-2 691

Further inquiry note